Literature DB >> 8016005

Impaired glucose tolerance and diabetes mellitus in a suburban Sri Lankan community.

D J Fernando1, S Siribaddana, D de Silva.   

Abstract

The prevalence of impaired glucose tolerance and diabetes mellitus was studied in a suburban Sri Lankan community using 1985 WHO criteria. Oral 75 g glucose tolerance tests were performed on 633 subjects aged 30-64 years. The age-standardized prevalence rates for diabetes mellitus were 5.02 (95% CI 3.59-6.43) and impaired glucose tolerance 5.27 (95% CI 3.74-6.78). A total of 21% of diabetic patients were not known to have diabetes and were diagnosed for the first time during the survey. Obesity was more common (P < 0.05) in diabetic patients (21%) when compared to non-diabetic subjects (10.5%). Diabetes mellitus is a common health problem in Sri Lanka, and there is a need for developing national policies for its prevention and control.

Entities:  

Mesh:

Year:  1994        PMID: 8016005      PMCID: PMC2397623          DOI: 10.1136/pgmj.70.823.347

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  Diabetes in the elderly in a developing country.

Authors:  D J Fernando; C E de Silva; S F Nanayakkara; H H Samarasinghe
Journal:  Diabetes Res Clin Pract       Date:  1992-03       Impact factor: 5.602

2.  Epidemiology of diabetes mellitus.

Authors:  H D Weerasinghe
Journal:  Ceylon Med J       Date:  1967-09

3.  Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates.

Authors:  J A Morris; M J Gardner
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07

4.  Special needs of elderly diabetic patients.

Authors:  A J Sinclair; A H Barnett
Journal:  BMJ       Date:  1993-05-01

5.  Diabetes in adults is now a Third World problem. The WHO Ad Hoc Diabetes Reporting Group.

Authors:  H King; M Rewers
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

6.  Relationship between prevalence of impaired glucose tolerance and NIDDM in a population.

Authors:  G K Dowse; P Z Zimmet; H King
Journal:  Diabetes Care       Date:  1991-11       Impact factor: 19.112

7.  High prevalence of diabetes in an urban population in south India.

Authors:  A Ramachandran; M V Jali; V Mohan; C Snehalatha; M Viswanathan
Journal:  BMJ       Date:  1988-09-03

8.  Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group.

Authors:  H King; M Rewers
Journal:  Diabetes Care       Date:  1993-01       Impact factor: 19.112

9.  Association of foot lesions with retinopathy in patients with newly diagnosed diabetes.

Authors:  C H Walsh; N G Soler; M G Fitzgerald; J M Malins
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

  9 in total
  4 in total

1.  Trends in prevalence of diabetes in Asian countries.

Authors:  Ambady Ramachandran; Chamukuttan Snehalatha; Ananth Samith Shetty; Arun Nanditha
Journal:  World J Diabetes       Date:  2012-06-15

2.  Social, cultural and economical determinants of diabetes mellitus in Kalutara district, Sri Lanka: a cross sectional descriptive study.

Authors:  Ambepitiyawaduge Pubudu De Silva; Sudirikku Hennadige Padmal De Silva; Isurujith Kongala Liyanage; Lalini Chandika Rajapakse; Kosala Saroj Amarasiri Jayasinghe; Prasad Katulanda; Chandrika Neelakanthi Wijeratne; Sumedha Wijeratne
Journal:  Int J Equity Health       Date:  2012-12-13

Review 3.  Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis.

Authors:  Ranil Jayawardena; Priyanga Ranasinghe; Nuala M Byrne; Mario J Soares; Prasad Katulanda; Andrew P Hills
Journal:  BMC Public Health       Date:  2012-05-25       Impact factor: 3.295

4.  Prevalence, trends and associated socio-economic factors of obesity in South Asia.

Authors:  Ranil Jayawardena; Nuala M Byrne; Mario J Soares; Prasad Katulanda; Andrew P Hills
Journal:  Obes Facts       Date:  2013-10-08       Impact factor: 3.942

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.